Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CMCSA | VZ |
|---|---|---|
| Price | $22.15 | $47.27 |
| Change today | ▼ 1.77% | ▲ 1.60% |
| Market cap | $78.61B | $196.38B |
| Return, 3 months | -0.8% | +5.2% |
| Return, year to date | -17.9% | +21.9% |
| Return, 1 year | -21.6% | +16.9% |
| P/E (TTM) | 7.1 | 12.3 |
| P/B | 0.9 | 1.9 |
| P/E percentile vs own 5y | 20th | 80th |
| Dividend yield | 5.96% | 5.91% |
| Revenue growth (YoY, latest qtr) | -1.2% | -0.7% |
| Net profit growth (YoY) | -69.0% | -22.9% |
| Gross margin | 69.4% | 59.3% |
| Operating margin | 14.7% | 20.5% |
| Net margin | 9.0% | 11.6% |
| Return on equity | 12.0% | 15.6% |
| Analyst target vs. price | +32.2% | +5.9% |
| Analyst buy share | 38% | 36% |
| RSI (14) | 33 | 37 |
| 30-day volatility | 33.7% | 21.7% |
| Max drawdown, 1 year | -30.8% | -17.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.